LU86397A1 - - Google Patents

Download PDF

Info

Publication number
LU86397A1
LU86397A1 LU86397A LU86397A LU86397A1 LU 86397 A1 LU86397 A1 LU 86397A1 LU 86397 A LU86397 A LU 86397A LU 86397 A LU86397 A LU 86397A LU 86397 A1 LU86397 A1 LU 86397A1
Authority
LU
Luxembourg
Prior art keywords
compound
acid
ethyl
effect
trans
Prior art date
Application number
LU86397A
Other languages
German (de)
English (en)
Inventor
Csaba Szantay
Laszlo Szporny
Lajos Szabo
Gyoergy Kalaus
Zsolt Szombathelyi
Egon Karpati
Bela Kiss
Katalin Csomor
Istvan Laszlovszky
Erzsebet Lapis
Lilla Forgacs
Csaba Kuthi
Aniko Gere
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LU86397A1 publication Critical patent/LU86397A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
LU86397A 1985-04-19 1986-04-18 LU86397A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU851519A HU194221B (en) 1985-04-19 1985-04-19 Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound
HU151985 1985-04-19

Publications (1)

Publication Number Publication Date
LU86397A1 true LU86397A1 (ru) 1986-09-02

Family

ID=10954847

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86397A LU86397A1 (ru) 1985-04-19 1986-04-18

Country Status (35)

Country Link
US (1) US4806545A (ru)
JP (1) JPH072637B2 (ru)
CN (1) CN1023560C (ru)
AR (1) AR240699A1 (ru)
AT (1) AT390954B (ru)
AU (1) AU591896B2 (ru)
BE (1) BE904588A (ru)
BG (1) BG60433B2 (ru)
CA (1) CA1299574C (ru)
CH (1) CH668262A5 (ru)
CS (1) CS274276B2 (ru)
DD (1) DD244556A5 (ru)
DE (1) DE3613180C2 (ru)
DK (1) DK159780C (ru)
EG (1) EG18059A (ru)
ES (1) ES8706152A1 (ru)
FI (1) FI83870C (ru)
FR (1) FR2580649B1 (ru)
GB (1) GB2174701B (ru)
GR (1) GR861027B (ru)
HU (1) HU194221B (ru)
IE (1) IE59199B1 (ru)
IL (1) IL78538A (ru)
IN (1) IN162810B (ru)
IT (1) IT1204306B (ru)
LU (1) LU86397A1 (ru)
NL (1) NL8600976A (ru)
NO (1) NO167143C (ru)
NZ (1) NZ215879A (ru)
PH (1) PH25316A (ru)
PT (1) PT82424B (ru)
SE (1) SE460196B (ru)
SU (1) SU1438612A3 (ru)
YU (1) YU44286B (ru)
ZA (1) ZA862941B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191454B (en) * 1984-10-05 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt.,Hu Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof
HU207070B (en) * 1990-10-31 1993-03-01 Richter Gedeon Vegyeszet Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
CA2480695A1 (en) * 2002-04-03 2003-10-09 Orion Corporation Polycyclic compounds as potent alpha2-adrenoceptor antagonists
JPWO2003094917A1 (ja) * 2002-05-13 2005-09-08 高田製薬株式会社 ビントペロール含有経皮投与用医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499546A (en) * 1974-05-07 1978-02-01 Richter Gedeon Vegyeszet Indolo-quinolizidine derivatives and a process for the preparation thereof
HU170495B (ru) * 1974-05-07 1977-06-28
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof

Also Published As

Publication number Publication date
DK159780B (da) 1990-12-03
NZ215879A (en) 1989-04-26
DK159780C (da) 1991-04-22
IT1204306B (it) 1989-03-01
YU44286B (en) 1990-04-30
EG18059A (en) 1991-06-30
PT82424A (en) 1986-05-01
IN162810B (ru) 1988-07-09
NO167143B (no) 1991-07-01
AT390954B (de) 1990-07-25
GB2174701A (en) 1986-11-12
FI861641A0 (fi) 1986-04-18
CS274276B2 (en) 1991-04-11
DK179786A (da) 1986-10-20
IT8620136A0 (it) 1986-04-18
BE904588A (fr) 1986-10-14
HU194221B (en) 1988-01-28
CN1023560C (zh) 1994-01-19
AR240699A1 (es) 1990-09-28
AU5638386A (en) 1986-10-23
BG60433B2 (bg) 1995-03-31
JPH072637B2 (ja) 1995-01-18
ES8706152A1 (es) 1987-06-01
CN86102479A (zh) 1986-10-22
JPS61249986A (ja) 1986-11-07
IE861033L (en) 1986-10-19
NO167143C (no) 1991-10-09
IL78538A (en) 1989-10-31
FR2580649A1 (fr) 1986-10-24
GB2174701B (en) 1989-02-15
HUT40433A (en) 1986-12-28
AU591896B2 (en) 1989-12-21
NL8600976A (nl) 1986-11-17
DD244556A5 (de) 1987-04-08
FI83870C (fi) 1991-09-10
ES554143A0 (es) 1987-06-01
GB8609533D0 (en) 1986-05-21
CH668262A5 (de) 1988-12-15
YU62486A (en) 1988-06-30
ZA862941B (en) 1986-12-30
DE3613180C2 (de) 1995-10-19
NO861539L (no) 1986-10-20
SU1438612A3 (ru) 1988-11-15
IE59199B1 (en) 1994-01-26
ATA102986A (de) 1990-01-15
SE8601799D0 (sv) 1986-04-18
PH25316A (en) 1991-04-30
FI861641A (fi) 1986-10-20
FI83870B (fi) 1991-05-31
CS286386A2 (en) 1990-09-12
CA1299574C (en) 1992-04-28
PT82424B (pt) 1988-03-03
US4806545A (en) 1989-02-21
GR861027B (en) 1986-08-12
DE3613180A1 (de) 1986-10-23
SE460196B (sv) 1989-09-18
SE8601799L (sv) 1986-10-20
IL78538A0 (en) 1986-08-31
FR2580649B1 (fr) 1991-03-29
DK179786D0 (da) 1986-04-18

Similar Documents

Publication Publication Date Title
DE2445584C3 (de) L- bzw. DL-2-Methyl-3- (3', 4'-dihydroxyphenyl)-alanin-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE2305092C2 (ru)
DE3825962A1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2653257C2 (ru)
DE2439859A1 (de) Verfahren zur herstellung von 3-(3,4dihydroxy-phenyl)-serin
CH626344A5 (ru)
DE2253750C3 (de) Apovincaminsaure-alkylester, Verfahren zu ihrer Herstellung und pharmazeutische
AT390954B (de) Verfahren zur herstellung des neuen (-)-1beta|thyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12, 12b alpha-octahydroindolo(2,3-a) chinolizins und von dessen saeureadditionssalzen
DE1911464C3 (de) 3,4-Dihydroisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
DE2807643C2 (ru)
EP0086416A2 (de) Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3314878C2 (ru)
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE2717001A1 (de) Arzneimittel mit antithrombotischer wirkung
CH635342A5 (de) Verfahren zur herstellung von neuen octahydro-indolo(2,3-a)-chinolizinen.
DE2912026C2 (ru)
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel
DE3807595A1 (de) Optisch aktive oxo-isoindolinyl-derivate und verfahren zu deren herstellung
DD200404A5 (de) Verfahren zur herstellung eines synergistisch wirkenden mittels
DE2609533A1 (de) Verfahren zur extraktion von wirkstoffen, insbesondere von heterosidestern, der kaffeesaeure, sowie diese verbindungen enthaltende arzneimittel
CH624397A5 (ru)
DE1232966B (de) Verfahren zur Herstellung von (+)-Enantiomorphen von Indolverbindungen
DE2733056C2 (de) Vincamenin und seine Säureadditionssalze, solche enthaltende Arzneimittel sowie Verfahren zur Herstellung der genannten Verbindungen
DE3324727C2 (ru)